Clinical utility of different assay designs
| Clinical utility . | Single gene . | Gene panel . | Whole exome . | Genome-wide . |
|---|---|---|---|---|
| Cancer genome profile | No | Target-gene approach | Yes | Yes |
| Prognostic | One at a time | Yes | Yes | Yes |
| Identification of target-therapeutics | One at a time | Yes | Yes | Yes |
| Immuno-oncology | No | Maybe | Maybe | Maybe |
| Cancer predisposition | One at a time | If germ line included | Yes | Yes |
| Diagnostic (classification) | One at a time | Comprehensive | Yes | Yes |
| Monitoring | Ultrasensitive | Comprehensive | Comprehensive | Comprehensive |
| Minimal disease detection | Ultrasensitive | Comprehensive | No | No |
| Detecting unexpected findings | No | Limited | yes | yes |
| Clinical utility . | Single gene . | Gene panel . | Whole exome . | Genome-wide . |
|---|---|---|---|---|
| Cancer genome profile | No | Target-gene approach | Yes | Yes |
| Prognostic | One at a time | Yes | Yes | Yes |
| Identification of target-therapeutics | One at a time | Yes | Yes | Yes |
| Immuno-oncology | No | Maybe | Maybe | Maybe |
| Cancer predisposition | One at a time | If germ line included | Yes | Yes |
| Diagnostic (classification) | One at a time | Comprehensive | Yes | Yes |
| Monitoring | Ultrasensitive | Comprehensive | Comprehensive | Comprehensive |
| Minimal disease detection | Ultrasensitive | Comprehensive | No | No |
| Detecting unexpected findings | No | Limited | yes | yes |